Premium
Unraveling the metabolic and machinery constraints on protein secretion through a novel systems biology framework
Author(s) -
Lewis Nathan E.
Publication year - 2020
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2020.34.s1.02797
Subject(s) - secretion , secretory protein , biology , chinese hamster ovary cell , microbiology and biotechnology , secretory pathway , systems biology , computational biology , biochemistry , cell culture , endoplasmic reticulum , genetics , golgi apparatus
In mammalian cells, metabolism is a core process driving homeostasis, but variations in other cell processes largely define cell type identity and cell‐type specific functions. The profile of secreted and membrane proteins show substantial cell‐type specificity and drive many tissue specific functions. These proteins, encoded by up to 1/3 of mammalian protein‐coding genes, include hormones, membrane proteins, and extracellular enzymes, and these are synthesized and trafficked through the secretory pathway. The pathway complexity, however, obfuscates its impact on the secretion of different proteins. Unraveling its impact on diverse proteins is particularly important since the pathway is implicated in many diseases and harnessed for biopharmaceutical production. Through the use of network reconstruction approaches and protein interaction assays, we have mapped out the core secretory pathway and integrated it with our genome‐scale metabolic models of human, mouse, and Chinese hamster ovary cells. We first deploy graph‐based approaches to evaluate the dependency of protein secretion on diverse human secreted proteins. We then deployed constraint‐based modeling to quantify the bioenergetic demands for the synthesis and secretion of these proteins. Finally, we deployed these models to engineer mammalian cells for enhanced secretion of high‐value biologic drugs. Thus, we present a platform that enables the study and engineering of the mammalian secretory pathway and metabolism for systems biotechnology. Support or Funding Information NIGMS R35 GM119850 and the Novo Nordisk Foundation Center for Biosustainability NNF10CC1016517